Rolapitant

Rolapitant is an azaspiro compound that is 1,7-diazaspiro[4.5]decan-2-one carrying additional phenyl and 1-{[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl substituents at position 8. Used (in the form of the hydrochloride hydrate) for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. Among its listed roles, it functions as a antiemetic and a neurokinin-1 receptor antagonist. It is an ether, a member of piperidines, an azaspiro compound, an organofluorine compound and a member of pyrrolidin-2-ones. It is the conjugate base of rolapitant(1+). It is grouped under the following drug class(es): Antiemetics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Varuby and rolapitantum. Its PubChem CID is 10311306.

CAS No 552292-08-7
Molecular Formula C25H26F6N2O2
Molecular Weight 500.50 g/mol
Synonyms (5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one

Frequently Asked Questions